Feeds › 8-K events
8-K events
Major news companies must report to the SEC: results, deals, leadership changes.
About this data
- What it is
- A Form 8-K is how a public company announces major news between its quarterly reports: earnings, an acquisition, a new CEO, a cybersecurity incident. Each filing lists the numbered items it covers.
- Who files it
- The company, usually within four business days of the event.
- How current
- We collect new filings throughout the day on SEC business days.
- Worth knowing
- Many 8-Ks are routine, so the item description is the place to start. Item 9.01, which only lists attached documents, is hidden unless you ask for it.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
8-K items filed per day, last 30 days
All items Earnings results (2.02)
One filing can report several items. Item 9.01, which only lists attached documents, is not counted.
Latest 8-K filings
Showing: ticker MLYS
| Filed | Company | Item | Form | Filing |
|---|---|---|---|---|
| Nov 4, 2026 | MLYS Mineralys Therapeutics, Inc. | 5.02 Departure or Election of Directors or Officers; Compensatory Arrangements | 8-K | 8-K ↗ |
| Nov 4, 2026 | MLYS Mineralys Therapeutics, Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Oct 29, 2026 | MLYS Mineralys Therapeutics, Inc. | 1.02 Termination of a Material Definitive Agreement | 8-K | 8-K ↗ |
| Oct 29, 2026 | MLYS Mineralys Therapeutics, Inc. | 1.01 Entry into a Material Definitive Agreement | 8-K | 8-K ↗ |
| Oct 19, 2026 | MLYS Mineralys Therapeutics, Inc. | 5.02 Departure or Election of Directors or Officers; Compensatory Arrangements | 8-K | 8-K ↗ |
| Aug 11, 2026 | MLYS Mineralys Therapeutics, Inc. | 5.02 Departure or Election of Directors or Officers; Compensatory Arrangements | 8-K | 8-K ↗ |
| Aug 11, 2026 | MLYS Mineralys Therapeutics, Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Jun 3, 2026 | MLYS Mineralys Therapeutics, Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Jun 3, 2026 | MLYS Mineralys Therapeutics, Inc. | 2.03 Creation of a Direct Financial Obligation | 8-K | 8-K ↗ |
| Jun 3, 2026 | MLYS Mineralys Therapeutics, Inc. | 1.01 Entry into a Material Definitive Agreement | 8-K | 8-K ↗ |
| May 22, 2026 | MLYS Mineralys Therapeutics, Inc. | 5.07 Submission of Matters to a Vote of Security Holders | 8-K | 8-K ↗ |
| May 6, 2026 | MLYS Mineralys Therapeutics, Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Mar 12, 2026 | MLYS Mineralys Therapeutics, Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Mar 9, 2026 | MLYS Mineralys Therapeutics, Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Mar 9, 2026 | MLYS Mineralys Therapeutics, Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Jan 6, 2026 | MLYS Mineralys Therapeutics, Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Jan 6, 2026 | MLYS Mineralys Therapeutics, Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Nov 10, 2025 | MLYS Mineralys Therapeutics, Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Sep 3, 2025 | MLYS Mineralys Therapeutics, Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Sep 2, 2025 | MLYS Mineralys Therapeutics, Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Aug 12, 2025 | MLYS Mineralys Therapeutics, Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Jun 17, 2025 | MLYS Mineralys Therapeutics, Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Jun 17, 2025 | MLYS Mineralys Therapeutics, Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| May 22, 2025 | MLYS Mineralys Therapeutics, Inc. | 5.07 Submission of Matters to a Vote of Security Holders | 8-K | 8-K ↗ |
| May 12, 2025 | MLYS Mineralys Therapeutics, Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Mar 31, 2025 | MLYS Mineralys Therapeutics, Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Mar 31, 2025 | MLYS Mineralys Therapeutics, Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Mar 12, 2025 | MLYS Mineralys Therapeutics, Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Mar 10, 2025 | MLYS Mineralys Therapeutics, Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Mar 10, 2025 | MLYS Mineralys Therapeutics, Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Feb 12, 2025 | MLYS Mineralys Therapeutics, Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Feb 4, 2025 | MLYS Mineralys Therapeutics, Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Feb 4, 2025 | MLYS Mineralys Therapeutics, Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Jan 8, 2025 | MLYS Mineralys Therapeutics, Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Jan 8, 2025 | MLYS Mineralys Therapeutics, Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Nov 12, 2024 | MLYS Mineralys Therapeutics, Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Oct 30, 2024 | MLYS Mineralys Therapeutics, Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Oct 30, 2024 | MLYS Mineralys Therapeutics, Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
38 items, most recent first (up to 50). Every row links to its original filing. Updated Nov 15, 2026, 4:53 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Insider trades · Planned insider sales · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances